A total of 9 genetic polymorphisms in the 3’-UTR of HLA-G gene were analyzed to determine the association of these genotypes with the risks of adverse outcomes post-HSCT, including mortality, disease relapse, and GVHD. This evidence concerns the gene HLA-G and graft versus host disease.